Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Affymetrix, Inc.
New Cytogenetics Products Offer Best Overall Approach for Detection of Chromosome Aberrations
April 10th, 2009
Today, Affymetrix, Inc. (Nasdaq: AFFX) launched its next-generation series of products for cytogenetics. The entirely new solution, which includes arrays, reagents, and software, enables fast and reliable detection of known and novel chromosome aberrations. “We worked closely with the cytogenetics community to develop these products,” said Jay Kaufman, vice president of product marketing at Affymetrix. “We identified critical and high-demand features specific to cytogenetics studies, and leveraged our proven microarray platform to develop products that delivered those features. Then, we streamlined and simplified workflows and protocols from sample preparation to data...
Source: Health Business Week (2009-04-10)
|
